144 related articles for article (PubMed ID: 1256656)
1. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
Florio F; Ruffolo S; Piro E
Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
[No Abstract] [Full Text] [Related]
2. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
Andalò L; Missana M
Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
[No Abstract] [Full Text] [Related]
3. [Our experience in the treatment of peripheral vascular diseases with raubasine].
Vercellio G; Costantini S; Giulini S
Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
[No Abstract] [Full Text] [Related]
4. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
Hamming JJ; van der Drift JH
Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
[No Abstract] [Full Text] [Related]
5. [On the therapy of cerebral and peripheral circulatory disorders in general practice].
Risse S
Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140
[No Abstract] [Full Text] [Related]
6. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
Bock KJ
Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
[No Abstract] [Full Text] [Related]
7. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
Sauter R
Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
[No Abstract] [Full Text] [Related]
8. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
[No Abstract] [Full Text] [Related]
9. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
Lefebvre P; Crocq L; Bernard JG
Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
[No Abstract] [Full Text] [Related]
10. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
Laveant-Hebrard C; Camus JP
Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
[No Abstract] [Full Text] [Related]
11. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
Prosenz P; Tschabitscher H
Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
[No Abstract] [Full Text] [Related]
12. [Report on the clinical trial with lamuran (II)].
Steinorth G
Med Welt; 1967 Sep; 36():2110-5. PubMed ID: 5614247
[No Abstract] [Full Text] [Related]
13. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
Offerhaus L
Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
[No Abstract] [Full Text] [Related]
14. [Harmful effects of vasodilator therapy].
Bartolo M; Ortisi U
Minerva Med; 1971 Feb; 62(16):724-9. PubMed ID: 5549393
[No Abstract] [Full Text] [Related]
15. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
Probst G; Keiser G
Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
[No Abstract] [Full Text] [Related]
16. [Ginkgo-biloba in the therapy of vascular diseases].
Sorbini E
Minerva Med; 1973 Nov; 64(79 Suppl):4201-8. PubMed ID: 4592298
[No Abstract] [Full Text] [Related]
17. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
Buckert D; Harwart D
Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
[No Abstract] [Full Text] [Related]
18. [Ophthalmological use of bencyclane and ophthalmodynamometric recording of its effect on cerebral vessels].
Födö V
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1450+. PubMed ID: 5536669
[No Abstract] [Full Text] [Related]
19. [Value of drugs acting on the smooth musculature by direct and indirect routes in therapy of vascular diseases].
Labò G; Pretolani E
Cardiol Prat; 1971 Feb; 22(1):1-9. PubMed ID: 4398064
[No Abstract] [Full Text] [Related]
20. [Treatment of peripheral vascular disorders with dilatol].
Knapik Z; Twardzicki J; Wlodarczykowa J
Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
